Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.5 CHF | +3.25% | +9.34% | +26.06% |
05-03 | Basilea Reports Presentation of New Data for Ceftobiprole (Zevtera®) At Escmid Global 2024 | CI |
04-09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BASILEA PHARMACEUTICA AG | Other Biotechnology & Medical Research | +3.25% | +9.34% | +26.06% | -3.78% | +8.48% | 573M |
Technical Rankings Surperformance
- Stock Market
- Equities
- BSLN Stock
- Charts Basilea Pharmaceutica AG
- Comparison Chart